FDA Inspection 760152 — Acclarent, Inc.

Acclarent, Inc. — FEI 3005172759

The FDA completed an inspection of Acclarent, Inc. on February 24, 2012 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 24, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Irvine, CA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
319221 CFR 820.30(g)Design validation - user needs and intended uses
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate